Definitive Contract W81XWH22C0046
Award Date
8/22/22
Potential Completion Date
12/21/25
Potential Value
$4.3M
Funding Federal Agency
Medical Command
Contracting Federal Agency
Defense Health Agency
Awardee
Cytosorbents Medical Inc.
Ultimate Awardee
Cytosorbents Corporation
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Set-Aside Type
Total Small Business
Federal Contract Vehicle
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Monmouth Junction, South Brunswick Township, NJ 08852, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase III Action
Primary Consortia Member
Not listed
Similar Awards
This $1.1 million firm fixed price contract was awarded by the Department of the Army Medical Command to Cytosorbents Medical Inc., doing business as Cytosorbents, to support research and development of an adsorber to remove anti-A and anti-B antibodies from plasma for transfusion under the Small Business Innovation Research (SBIR) Program Phase II solicitation. As a total small business set-aside, the contract aims to further the prime contractor's development of an effective adsorber that...
This contract was awarded by the Department of the Army Medical Command to Cytosorbents Medical Inc., doing business as Cytosorbents, a for-profit small business manufacturer of medical devices and technologies. The $999,871.34 fixed-price level of effort contract is for Phase II of a Small Business Innovation Research (SBIR) project to develop blood purification technologies. Cytosorbents, as the prime contractor, is providing research and prototype development services to the Defense Health...
This is a $999,996.59 firm-fixed-price Phase II SBIR contract awarded by the Joint PEO Chemical and Biological Defense to Cytosorbents Medical Inc., a small business manufacturer of medical devices and technologies. The contract is for research and prototype development services related to Cytosorbents' blood purification technologies, including an extracorporeal cytokine adsorber, a potassium adsorber, and a blood group antibody adsorber. These technologies are intended to treat critical care...
This federal contract award, with a ceiling value of $149,927.17, was issued by the U.S. Medical Command (MEDCOM) to Cytosorbents Medical Inc., a small business manufacturer of medical devices and technologies. The contract is for a SBIR Phase I research project under the Defense Health Program (DHP), with the goal of developing an extracorporeal cytokine adsorber to treat septic shock. As a small business set-aside, Cytosorbents is the prime contractor responsible for conducting the research to...
This is a $149,979 firm-fixed-price Definitive Contract awarded by the United States Army Medical Command (MEDCOM) to Cytosorbents Medical Inc., a small business manufacturer of medical devices and technologies. The contract was awarded under the Small Business Innovation Research (STTR) program for Phase I research, with the goal of developing an extracorporeal cytokine adsorber to treat septic shock. As a small business, this contract award was set aside for Cytosorbents as the prime...
This is a $1,499,987.16 Firm Fixed Price Definitive Contract awarded by the U.S. Army Medical Command (MEDCOM) to Cytosorbents Medical Inc., a small business manufacturer, under the Small Business Innovation Research (SBIR) program. The contract is for medical research and development to investigate a potassium adsorber for treating hyperkalemia resulting from traumatic injury and acute kidney injury in austere environments. This is a Phase II SBIR action with a completion date of February 20,...
The Air Force has awarded a $2,959,747 cost-plus-fixed-fee contract to Cytosorbents Medical Inc. to provide the K+ONTROL Renal Support System for Reduction of Hyperkalemia. This definitive contract has an ultimate completion date of September 27, 2023. Cytosorbents is a for-profit manufacturer that develops blood purification technologies to treat critical care conditions. The company has previously received research and development funding from the National Institutes of Health and Department...
The Department of the Army Medical Command awarded a $166,492.05 Small Business Innovation Research (SBIR) Phase I contract to CFD Research Corporation, doing business as CFD Research, for the development of a "Portable Automated Phage Isolation Technology." This firm-fixed-price contract was set aside for small businesses. CFD Research, a for-profit engineering and technology services firm, has a history of providing computational fluid dynamics research, artificial intelligence,...
This firm fixed-price purchase order contract was awarded by the Defense Health Agency (DHA) to Cerus Corporation, a biomedical products company specializing in blood safety technologies and pathogen reduction systems. The $369,384 contract is for the provision of Cerus' proprietary INTERCEPT Blood System, which uses riboflavin and ultraviolet light to inactivate pathogens in blood components, including platelets and plasma. This pathogen reduction technology plays a critical role in reducing...
This is a Small Business Innovation Research (SBIR) Phase III contract award from the Department of the Army Medical Command (MEDCOM) to Tissue Testing Technologies LLC, a small disadvantaged business. The $938,441.90 fixed-price level of effort contract is for the further development and optimization of rapid rewarming and cryoprotectant toxicity reduction techniques using magnetic nanoparticles, building on the company's prior SBIR Phase I and II research. The goal is to improve the...